Despite potential benefits, the therapy remains in limited use for myeloproliferative neoplasms (MPNs). Pegylated interferons are a meaningful therapeutic option for the treatment of ...

FDA analysis of toxicity profiles of oral TKIs recently approved for non-small cell lung cancer based on receipt of prior immune checkpoint inhibitor therapy.

Hemispherx Biopharma Inc has acquired certain assets from Interferon Sciences, Inc. (IFSC), a biotechnology company, including the rights to its patented drug, the Alferon N Injection, approved by the ...